The clinical and cost effectiveness of biventricular pacing for patients with severe heart failure: addendum report ; January 2005 [updated January 2006]

Taylor R
Record ID 32006000735
Authors' objectives:

The aim of this report was to assess the clinical and cost effectiveness of biventricular pacing for patients with severe heart failure.

Authors' recommendations: BVP (without combination with an ICD) appears to be a clinically effective adjunct to optimal medical treatment in selected heart failure patients. However, its cost effectiveness remains less certain although a recent analysis (based on the CARE-HF trial) indicates that BVP seems to be cost effective from a UK NHS perspective.The cost effective implementation of BVP within the West Midlands is likely to depend on cost of the BVP procedure (device and staffing) to the local health economy as well as the careful application of criteria for selection of suitable patients. Further research is needed to assess the place of BVP combined with ICD in the management of heart failure, and to identify those patients where BVP is likely to most cost effective.NICE is due to issue guidance to NHS in England and Wales on cardiac resynchronisation therapy in severe heart failure in March 2007
Authors' methods: Systematic review
Project Status: Completed
Year Published: 2005
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England
MeSH Terms
  • Cardiac Pacing, Artificial
  • Costs and Cost Analysis
  • Heart Failure
Organisation Name: West Midlands Health Technology Assessment Collaboration
Contact Address: Elaena Donald-Lopez, West Midlands Health Technology Assessment Collaboration, Department of Public Health and Epidemiology, University of Birmingham, Edgbaston, Birmingham B15 2TT Tel: +44 121 414 7450; Fax: +44 121 414 7878
Contact Name:
Contact Email:
Copyright: University of Birmingham
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.